BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

Genmab and Bolt Biotherapeutics Announce Oncology Research and Development Collaboration

02 6 2021 08:00:02 提供 Nasdaq GlobeNewswire

Bolt Biotherapeutics Reports First Quarter 2021 Financial Results and Provides Business Highlights

13 5 2021 16:05:00 提供 Nasdaq GlobeNewswire

Bolt Biotherapeutics Announces AACR 2021 Presentation of Boltbody™ Platform Mechanism of Action and Clinical Properties of Lead ISAC, BDC-1001

10 4 2021 08:30:00 提供 Nasdaq GlobeNewswire

Bolt Biotherapeutics to Present at 20th Annual Needham Virtual Healthcare Conference

08 4 2021 07:00:00 提供 Nasdaq GlobeNewswire

Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights

31 3 2021 16:05:00 提供 Nasdaq GlobeNewswire

Bolt Biotherapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

09 2 2021 16:05:00 提供 Nasdaq GlobeNewswire